questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Azépines
Azépines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Azépines : Questions médicales les plus fréquentes",
"headline": "Azépines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Azépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-14",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Azépines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétéromonocycliques",
"url": "https://questionsmedicales.fr/mesh/D006573",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétéromonocycliques",
"code": {
"@type": "MedicalCode",
"code": "D006573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dilazep",
"alternateName": "Dilazep",
"url": "https://questionsmedicales.fr/mesh/D004109",
"about": {
"@type": "MedicalCondition",
"name": "Dilazep",
"code": {
"@type": "MedicalCode",
"code": "D004109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Meptazinol",
"alternateName": "Meptazinol",
"url": "https://questionsmedicales.fr/mesh/D008621",
"about": {
"@type": "MedicalCondition",
"name": "Meptazinol",
"code": {
"@type": "MedicalCode",
"code": "D008621",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépines",
"alternateName": "Oxazepines",
"url": "https://questionsmedicales.fr/mesh/D010077",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépines",
"code": {
"@type": "MedicalCode",
"code": "D010077",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.498"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pentétrazol",
"alternateName": "Pentylenetetrazole",
"url": "https://questionsmedicales.fr/mesh/D010433",
"about": {
"@type": "MedicalCondition",
"name": "Pentétrazol",
"code": {
"@type": "MedicalCode",
"code": "D010433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.600"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Azépines",
"alternateName": "Azepines",
"code": {
"@type": "MedicalCode",
"code": "D001381",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peng An",
"url": "https://questionsmedicales.fr/author/Peng%20An",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Ranran Li",
"url": "https://questionsmedicales.fr/author/Ranran%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Bin Zhang",
"url": "https://questionsmedicales.fr/author/Bin%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Yi-Kang Zhang",
"url": "https://questionsmedicales.fr/author/Yi-Kang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Sylvian Cretton",
"url": "https://questionsmedicales.fr/author/Sylvian%20Cretton",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38625439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10147-024-02503-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real world.",
"datePublished": "2024-03-20",
"url": "https://questionsmedicales.fr/article/38509492",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-024-12090-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep inspiratory breath-hold radiotherapy on a Helical Tomotherapy unit: Workflow and early outcomes in patients with left-sided breast cancer.",
"datePublished": "2024-03-17",
"url": "https://questionsmedicales.fr/article/38550657",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tipsro.2024.100244"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.",
"datePublished": "2024-03-16",
"url": "https://questionsmedicales.fr/article/38491334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10549-024-07288-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes.",
"datePublished": "2024-03-07",
"url": "https://questionsmedicales.fr/article/38453782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10549-024-07286-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Azépines",
"item": "https://questionsmedicales.fr/mesh/D001381"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Azépines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Azépines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Azépines",
"description": "Comment diagnostiquer un trouble d'anxiété ?\nQuels tests sont utilisés pour évaluer l'anxiété ?\nLes azépines sont-elles prescrites pour d'autres troubles ?\nQuels critères sont utilisés pour le diagnostic ?\nComment différencier l'anxiété normale de l'anxiété pathologique ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=999#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Azépines",
"description": "Quels sont les symptômes courants de l'anxiété ?\nLes azépines peuvent-elles provoquer des effets secondaires ?\nComment l'anxiété se manifeste-t-elle physiquement ?\nQuels signes indiquent une crise d'angoisse ?\nLes symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=999#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Azépines",
"description": "Comment prévenir les troubles anxieux ?\nLes techniques de relaxation sont-elles efficaces ?\nL'éducation sur l'anxiété peut-elle aider ?\nLe soutien social joue-t-il un rôle dans la prévention ?\nLes azépines peuvent-elles être utilisées en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=999#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Azépines",
"description": "Comment les azépines agissent-elles sur l'anxiété ?\nQuels sont les principaux azépines prescrites ?\nLes azépines sont-elles addictives ?\nComment se déroule un traitement avec azépines ?\nLes azépines peuvent-elles être combinées avec d'autres traitements ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=999#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Azépines",
"description": "Quelles complications peuvent survenir avec les azépines ?\nLes azépines peuvent-elles interagir avec d'autres médicaments ?\nQuels sont les risques d'un sevrage brutal ?\nLes azépines peuvent-elles affecter la mémoire ?\nComment gérer les complications liées aux azépines ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=999#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Azépines",
"description": "Quels sont les facteurs de risque pour l'anxiété ?\nL'âge influence-t-il le risque d'anxiété ?\nLe sexe joue-t-il un rôle dans l'anxiété ?\nLes antécédents médicaux augmentent-ils le risque ?\nLe mode de vie peut-il influencer l'anxiété ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=999#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble d'anxiété ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes et l'exclusion d'autres troubles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'anxiété ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles d'évaluation psychologique et des entretiens cliniques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les azépines sont-elles prescrites pour d'autres troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être utilisées pour les troubles du sommeil et les crises d'angoisse."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la durée des symptômes et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Comment différencier l'anxiété normale de l'anxiété pathologique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété pathologique est persistante, excessive et interfère avec le fonctionnement quotidien."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'anxiété ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'inquiétude excessive, l'irritabilité et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles provoquer des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme la somnolence, la confusion et des troubles de la mémoire peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'anxiété se manifeste-t-elle physiquement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des palpitations, des tremblements et des douleurs musculaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une crise d'angoisse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une peur intense, des palpitations, des sueurs et des sensations d'étouffement."
}
},
{
"@type": "Question",
"name": "Les symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en intensité et en type selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles anxieux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion du stress, l'exercice régulier et une bonne hygiène de vie peuvent aider."
}
},
{
"@type": "Question",
"name": "Les techniques de relaxation sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation et le yoga peuvent réduire l'anxiété."
}
},
{
"@type": "Question",
"name": "L'éducation sur l'anxiété peut-elle aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'anxiété et ses mécanismes peut aider à mieux la gérer."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon réseau de soutien social peut réduire le risque de troubles anxieux."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles être utilisées en prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont généralement pas recommandées pour la prévention en raison du risque de dépendance."
}
},
{
"@type": "Question",
"name": "Comment les azépines agissent-elles sur l'anxiété ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent l'effet du GABA, un neurotransmetteur inhibiteur, réduisant ainsi l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux azépines prescrites ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principales incluent le diazépam, le lorazépam et l'alprazolam."
}
},
{
"@type": "Question",
"name": "Les azépines sont-elles addictives ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation prolongée peut entraîner une dépendance et un sevrage difficile."
}
},
{
"@type": "Question",
"name": "Comment se déroule un traitement avec azépines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement commence généralement par une faible dose, ajustée selon la réponse du patient."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles être combinées avec d'autres traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être combinées avec des thérapies cognitivo-comportementales pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les azépines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dépendance, le sevrage et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles interagir avec d'autres médicaments ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec des antidépresseurs et des analgésiques, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'un sevrage brutal ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sevrage brutal peut entraîner des symptômes graves comme des convulsions et des hallucinations."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles affecter la mémoire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des troubles de la mémoire, surtout à forte dose ou sur le long terme."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux azépines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut une réduction progressive de la dose et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'anxiété ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, les antécédents familiaux et des événements traumatiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anxiété ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes et les personnes âgées sont souvent plus à risque."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans l'anxiété ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont généralement plus susceptibles de souffrir de troubles anxieux que les hommes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de dépression ou de troubles mentaux augmentent le risque d'anxiété."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il influencer l'anxiété ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
In the field of urology, robotic surgery has gained rapid and wide acceptance as a standard surgical approach in the majority of major surgeries over the last decade. To date, the da Vinci surgical sy...
Endometrial cancer is a prevalent gynecologic malignancy found in postmenopausal women. However, in the last two decades, the incidence of early-stage has doubled in women under 40 years old. This stu...
This retrospective study analyzed patients with early-stage endometrial cancer at 13 medical institutions in China from 1999 to 2015. The patients were divided into two groups: young (≤ 45 years old) ...
The study involved 1,280 patients, 150 of whom were 45 years old or younger. The young group exhibited a significantly higher proportion of stage II, low-risk, lower uterine segment infiltration (LUSI...
In the present study, young patients had better characteristics than the non-young group, while they exhibited higher levels of aggressiveness in certain aspects. The LRFS and OS outcomes were better ...
The clinical implementation of deep inspiratory breath-hold (DIBH) radiotherapy to reduce cardiac exposure in patients with left-sided breast cancer is challenging with helical tomotherapy(HT) and has...
The workflow incorporates staggered junctions and a frame that provides tactile feedback to the patient and monitoring for manual cut-off. The treatment parameters and clinical outcome of 20 patients ...
The mean dose (Dmean) to the heart was reduced by an average of 34 % in DIBH-HT compared to FB-HT plans (3.8 Gy vs 5.7 Gy). Similarly, 32 % and 67.8 % dose reduction were noted in the maximum dose (D0...
Our workflow for DIBH with Helical-Tomotherapy addresses patient safety, treatment precision and challenges specific to this treatment unit. The workflow prevents junction issues by varying daily brea...
This study focused on identifying a hereditary predisposition in women previously diagnosed with early-onset breast cancer through a retrospective outreach activity (Traceback). The objectives were to...
Three hundred and fifteen Traceback-eligible women diagnosed with breast cancer at 36-40 years in Southern Sweden between 2000 and 2019 were identified and offered an analysis of the genes ATM, BARD1,...
One hundred and seventy-six women underwent genetic testing and pathogenic variants were identified in 9.7%: ATM (n = 6), BARD1 (n = 1), BRCA1 (n = 3), CHEK2 (n = 5), and PALB2 (n = 2). Women with nor...
The insights from the participants' perspectives and sentiments throughout the process support the notion that the Traceback procedure is a safe and an appreciated complement to routine genetic counse...
The prognostic utility and biological correlates of neutrophil to lymphocyte ratio (NLR), a potential biomarker of the balance between immune response and the inflammatory status, are still uncertain ...
We analysed a cohort of 959 women with early breast cancer, mostly treated with neoadjuvant or adjuvant chemotherapy. Clinical and pathological data, survival, NLR (continuous and categorical) and str...
NLR was only weakly associated with Ki67, while no association was found for grade, histology, immunohistochemical subtype or stage. Lymphocyte infiltration of the tumor did not correlate with NLR (Rh...
These results question the utility of NLR as a prognostic biomarker in early breast cancer and suggest the lack of correlation of NLR with tumor microenvironment immune response....
Minimally invasive surgery on treatment of early-stage cervical cancer is debatable. Traditional approaches of colpotomy are considered responsible for an inferior oncological outcome. Evidence on whe...
To investigate the impact of Three-Dimensional (3D) laparoscopy compared to traditional laparotomy on serum tumor markers and coagulation function in patients diagnosed with early-stage Endometrial Ca...
The authors retrospectively analyzed the clinical data of 75 patients diagnosed with early-stage EC and categorized them into two groups based on the surgical techniques employed. The 3D group consist...
Postoperatively, serum levels of CA125, CA199, and HE4 were notably reduced in both groups on the third day, with the levels being more diminished in the 3D group than in the Laparotomy Group (p < 0.0...
When juxtaposed with traditional laparotomy, 3D laparoscopic surgery for early-stage EC appears to be more efficacious, characterized by reduced complications, and expedited recovery. It can effective...
Effective detection of bio-molecules relies on the precise design and preparation of materials, particularly in laser desorption/ionization mass spectrometry (LDI-MS). Despite significant advancements...
The prognosis of early non-small-cell lung cancer (eNSCLC) remains poor. An understanding of current therapies and outcomes can provide insights into how novel therapies can be integrated into clinics...
Gastrointestinal (GI) symptoms are common among breast cancer patients undergoing chemotherapy, negatively impacting treatment outcomes and quality of life. Evidence points to inflammatory processes a...
In this secondary analysis of a prospective cohort study, we analyzed baseline levels of inflammatory biomarkers (measured using a Luminex bead-immunoassay) and plasma levels of DHA, EPA, and FFA (mea...
The analysis included 31 female breast cancer patients (mean age ± SD = 50.5 ± 8.8; 89.6% receiving anthracycline-based chemotherapy). Higher levels of docosahexaenoic acid (DHA) and interleukin-8 (IL...
Baseline IL-8 and DHA predicted GI symptom progression in early-stage breast cancer patients undergoing chemotherapy. Future studies are required to evaluate how therapeutic intervention targeting the...